Study of CTX-M Type of Extended Spectrum β-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India

被引:0
作者
R. Mohamudha Parveen
Subha Manivannan
B. N. Harish
S. C. Parija
机构
[1] Jawaharlal Institute of Post Graduate Medical Education and Research,Department of Microbiology
来源
Indian Journal of Microbiology | 2012年 / 52卷
关键词
Extended spectrum β-lactamase; CTX-M types; Antibiotic resistance; Nosocomial isolates; South India;
D O I
暂无
中图分类号
学科分类号
摘要
Data on CTX-M type extended-spectrum β-lactamase (ESBL) produced by Gram-negative bacteria by molecular methods are limited from India. This study was conducted to investigate the prevalence of CTX-M type ESBL producing Escherichia coli and Klebsiella pneumoniae from nosocomial isolates in a tertiary care hospital in southern India. A total of 179 clinical isolates of K. pneumoniae (n = 72) and E. coli (n = 107) were obtained in a period of 3 months and assessed for ESBL production phenotypically. Associated resistance to a panel of antibiotics and Minimum Inhibitory Concentration for 3rd generation cephalosporins was determined. Phenotypically ESBL positive isolates were subjected to PCR for blaCTX-M gene using two sets of primers for the simultaneous detection of all the five major groups of CTX-M types. All the positive isolates were then subjected to a group specific PCR to detect the prevalent group. Out of 179 isolates, 156 (87.1%) were positive for ESBL phenotypically, which includes 39.2% of K. pneumoniae and 60.8% of E. coli. All of them were examined by PCR using two primers for the presence of blaCTX-M genes. Among the 156 phenotypic positive isolates, 124 (79.4%) were positive for blaCTX-M genes, of which 45 (36.2%) were K. pneumoniae, 79 (63.7%) were E. coli. When the 124 positive clinical isolates were further tested with CTX-M group-specific primers, all were positive for the CTX-M-1 group. Our findings document evidence of the high prevalence of multidrug resistant CTX-M group 1 type ESBL among nosocomial isolates in this region. High co-resistance to other non-β-lactam antibiotics is a major challenge for management of ESBL infections. This is alarming and calls for the judicious use of carbapenems, especially in developing countries. This has significant implications for patient management, and indicates the need for increased surveillance and for further molecular characterization of these isolates.
引用
收藏
页码:35 / 40
页数:5
相关论文
共 84 条
[1]  
Bush K(2001)New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy Clin Infect Dis 32 1085-1089
[2]  
Jacoby GA(2005)The new β-lactamases N Engl J Med 352 380-391
[3]  
Munoz-Price LS(2004)Growing group of extended-spectrum β-lactamases: the CTX-M enzymes Antimicrob Agents Chemother 48 1-14
[4]  
Bonnet R(2002)Early dissemination of CTX-M-derived enzymes in South America Antimicrob Agents Chemother 46 602-604
[5]  
Radice M(2004)Ambler class A extended-spectrum beta-lactamase-producing Antimicrob Agents Chemother 48 1204-1214
[6]  
Power P(2003) and Antimicrob Agents Chemother 47 790-793
[7]  
DiConza J(2003) spp. in Canadian hospitals Antimicrob Agents Chemother 51 631-638
[8]  
Gutkind G(2002)Clinical isolates of Antimicrob Agents Chemother 46 3739-3754
[9]  
Mulvey MR(1998) producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China Antimicrob Agents Chemother 42 1980-1984
[10]  
Bryce E(2007)Production of CTX-M-3 extended-spectrum beta-lactamases and IMP-1 metallo-beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000 in the Kinki region of Japan Clin Microbiol Infect 13 291-297